These results suggested that CYP2J2/EET reduces atrial fibrosis by disinhibition of MiR‐21 on Smad‐7 via activating PPAR‐γ in atrial fibroblasts, mitigating the AF substrate and the progression of AF. The gene discussed is CYP2J2; the disease is atrial fibrillation.